Derivative Instruments - Additional Information (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | 12 Months Ended | ||||
|---|---|---|---|---|---|---|---|
Aug. 03, 2024 |
May 04, 2024 |
Jul. 29, 2023 |
Apr. 29, 2023 |
Aug. 03, 2024 |
Jul. 29, 2023 |
Feb. 03, 2024 |
|
| Derivative [Line Items] | |||||||
| Unrealized (loss) gain on derivatives | $ (7,848) | $ 6,372 | $ 3,915 | $ (984) | $ (1,476) | $ 2,931 | |
| Cash Flow Hedging [Member] | |||||||
| Derivative [Line Items] | |||||||
| Pre-tax gain (loss) deferred in reclassified to interest expense | $ 1,100 | $ (500) | 2,300 | $ (1,100) | |||
| Unrealized gains (losses) included in AOCI, before tax | (6,400) | $ (2,200) | |||||
| Unrealized (loss) gain on derivatives | (4,900) | $ (1,700) | |||||
| Estimated losses on interest rate caps deferred in AOCI reclassified to interest expense | $ 1,800 | ||||||
| X | ||||||||||
- Definition The estimated value of gains (losses), net anticipated to be transferred in the future from accumulated other comprehensive income into earnings. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before tax, after reclassification adjustments of other comprehensive income (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|